Literature DB >> 25370435

Albuminuria in prediabetes: time to intervene?

Venkata Ranga Rao Kodali1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25370435     DOI： 10.1007/s12020-014-0468-7

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  14 in total

1.  Lipid levels in subjects with impaired glucose tolerance.

Authors:  K V Ranga Rao; V Seshiah; S G Moses
Journal:  Indian J Med Res       Date:  1987-09       Impact factor: 2.375

2.  Ten-year follow-up of subjects with impaired glucose tolerance: prevention of diabetes by tolbutamide and diet regulation.

Authors:  G Sartor; B Scherstén; S Carlström; A Melander; A Nordén; G Persson
Journal:  Diabetes       Date:  1980-01       Impact factor: 9.461

3.  Disturbances in beta-cell function in impaired fasting glycemia.

Authors:  Timon W van Haeften; Walkyria Pimenta; Asimina Mitrakou; Mary Korytkowski; Trond Jenssen; Hannele Yki-Jarvinen; John E Gerich
Journal:  Diabetes       Date:  2002-02       Impact factor: 9.461

4.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

Authors: 
Journal:  Lancet       Date:  2000-01-22       Impact factor: 79.321

5.  Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.

Authors:  X R Pan; G W Li; Y H Hu; J X Wang; W Y Yang; Z X An; Z X Hu; J Lin; J Z Xiao; H B Cao; P A Liu; X G Jiang; Y Y Jiang; J P Wang; H Zheng; H Zhang; P H Bennett; B V Howard
Journal:  Diabetes Care       Date:  1997-04       Impact factor: 19.112

6.  Serum lipid and lipoprotein metabolism after glucose ingestion in NIDDM and IGT patients. Apolipoprotein-containing particles.

Authors:  T Nagai; T Tomizawa; S Minamide; K Nakajima; M Mori
Journal:  Diabetes Care       Date:  1996-04       Impact factor: 19.112

7.  Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.

Authors:  Jean-Louis Chiasson; Robert G Josse; Ramon Gomis; Markolf Hanefeld; Avraham Karasik; Markku Laakso
Journal:  Lancet       Date:  2002-06-15       Impact factor: 79.321

8.  Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes.

Authors:  Klaus Klausen; Knut Borch-Johnsen; Bo Feldt-Rasmussen; Gorm Jensen; Peter Clausen; Henrik Scharling; Merete Appleyard; Jan Skov Jensen
Journal:  Circulation       Date:  2004-06-21       Impact factor: 29.690

9.  XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients.

Authors:  Jarl S Torgerson; Jonathan Hauptman; Mark N Boldrin; Lars Sjöström
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

10.  Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians.

Authors:  S Lillioja; D M Mott; M Spraul; R Ferraro; J E Foley; E Ravussin; W C Knowler; P H Bennett; C Bogardus
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.